Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Pharma Equity Group A/S Director's Dealing 2014

Dec 30, 2014

Preview isn't available for this file type.

Download source file
{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

Hellerup, 2014-12-30 20:19 CET (GLOBE NEWSWIRE) -- Blue Vision A/S har modtaget
meddelelse fra fru Jeanette Borg, om, at fru Jeanette Borg pr. 29. december
2014 i forbindelse med kapitalforhøjelsen som omtalt i Selskabsmeddelelse nr.
27/2014 har erhvervet 4.783.798 stk. B-aktier i Blue Vision A/S svarende til
nominelt DKK 47.837.980 B-aktier.

Fru Jeanette Borg ejer herefter nominelt 47.837.980 B-aktier svarende til 45,59
% af den samlede aktiekapital og stemmerettigheder i Selskabet.

Hellerup, den 30. december 2014
Blue Vision A/S

Claus Abildstrøm
Bestyrelsesformand